On the afternoon of March 7, the Management Board of Ho Chi Minh City High-Tech Park coordinated with pharmaceutical companies and manufacturers with strengths in applying high technology in the fields of pharmaceuticals and biotechnology (CNSH) to organize a workshop: "Cooperation in research, development and application of CNSH at Ho Chi Minh City High-Tech Park".
The workshop aims to promote cooperation in developing and applying the biotechnology industry to develop the economy and society towards green growth.
Dr. Bui Dinh Thach, representative of the Institute of Tropical Biology - VAST, said that biotechnology is a high-tech field based on the foundation of life sciences, combined with technical processes and equipment to create technologies to exploit and produce high-quality biological products, serving socio-economic development and environmental protection. This is a key task and a development opportunity for the biopharmaceutical industry to make important breakthroughs in the research strategy to create quality products and develop human resources.
Currently, the application of biotechnology in the medical field includes: Development of biopharmaceuticals, pharmacogenomics, gene therapy...
Speaking at the workshop, Dr. Le Quoc Cuong, Deputy Head of the Management Board of the Ho Chi Minh City High-Tech Park, said that the Ho Chi Minh City People's Committee assigned the Ho Chi Minh City High-Tech Park Management Board to develop and implement the Ho Chi Minh City High-Tech Expansion Project with the goal of becoming a world-class high-tech park by 2030, operating according to the model of a science and technology park. In particular, prioritizing investment in high-tech development in the field of biotechnology is also one of the very important tasks.
BUI TUAN
Source
Comment (0)